Skip to main content

Table 4 The difference of TPS by staging

From: A prospective observational study to assess PD-L1 expression in small biopsy samples for non-small-cell lung cancer

 

TPS

high

low

no

undiagnosed

Adenocarcinoma

StageI, II

5

11

15

0

(%)

16.1

35.5

48.4

0

StageIII, IV

20

15

21

2

(%)

34.5

25.9

36.2

3.5

Squamous cell carcinoma

StageI, II

6

6

4

1

(%)

35.3

35.3

23.5

5.9

StageIII, IV

12

14

7

1

(%)

35.3

41.2

20.6

2.9